Multiple Numerical Chromosome Aberrations in Carcinogenesis: The Kidney Cancer Model

Por Manuel R. Teixeira
Publicado em 2009-01-01

Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications

Por Andreia Brandão, Paula Paulo, Manuel R. Teixeira
Publicado em 2020-07-01

Evaluation of Breast Cancer Polyclonality by Combined Chromosome Banding and Comparative Genomic Hybridization Analysis

Por Manuel R. Teixeira, Haroula Tsarouha, Sigrid M. Kraggerud, Nikos Pandis, Euthymios Dimitriadis, Johan A. Andersen, Ragnhild A. Lothe, Sverre Heim
Publicado em 2001-01-01

Novel 5′ Fusion Partners of ETV1 and ETV4 in Prostate Cancer

Por Joao D. Barros-Silva, Paula Paulo, Anne Cathrine Bakken, Nuno Cerveira, Marthe Løvf, Rui Henrique, Carmen Jerönimo, Ragnhild A. Lothe, Rolf Inge Skotheim, Manuel R. Teixeira
Publicado em 2013-07-01

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cel...

Por Nuno Cerveira, Rosa Branca Ferreira, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Fernando Campilho, Carlos Pinho Vaz, Luís Leite, Manuel R. Teixeira, António Campos
Publicado em 2018-12-01

Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.

Por João Ramalho-Carvalho, Malini Pires, Susana Lisboa, Inês Graça, Patrícia Rocha, João Diogo Barros-Silva, Joana Savva-Bordalo, Joaquina Maurício, Mário Resende, Manuel R Teixeira, Mrinalini Honavar, Rui Henrique, Carmen Jerónimo
Publicado em 2013-01-01

Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.

Por Maria J Camões, Paula Paulo, Franclim R Ribeiro, João D Barros-Silva, Mafalda Almeida, Vera L Costa, Nuno Cerveira, Rolf I Skotheim, Ragnhild A Lothe, Rui Henrique, Carmen Jerónimo, Manuel R Teixeira
Publicado em 2012-01-01

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

Por Nuno Cerveira, Bruno Loureiro, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Dulcineia Pereira, Cláudia Moreira, Sérgio Chacim, Nélson Domingues, Ana Espírito-Santo, Isabel Oliveira, Ilídia Moreira, Luísa Viterbo, Ângelo Martins, Manuel R. Teixeira, José M. Mariz
Publicado em 2018-12-01